Molward

MolWard provides a cloud-native platform for computational toxicology, de-risking pharmaceutical development from the earliest stages. Key features include: • Instant prediction of chemical degradation pathways • FDA CPCA nitrosamine hazard assessment • Absolute logic transparency for regulatory compliance • Zero-retention architecture for IP security • Seamless, zero-installation web access This platform eliminates the need for expensive, clunky legacy tools by offering a web-based service that instantly analyzes small molecules. It simulates hydrolytic, oxidative, photolytic, and thermal stress to map complete degradation pathways and generate MS fragmentation profiles, significantly accelerating SIM development. Furthermore, MolWard performs compliant dual-methodology hazard assessments, calculating FDA CPCA nitrosamine scores and acceptable intake limits, and extracting empirical read-across data. MolWard is built for regulatory compliance, providing the mechanistic transparency demanded by agencies. Every prediction is backed by Principal Component Analysis (PCA), demonstrating robust accuracy and discriminatory power based on extensive curated empirical records. This approach allows pharmaceutical and cheminformatics teams to shift risk assessment to the in-silico design phase, preventing unforeseen issues like unexpected degradants or toxicological alerts that can trigger costly clinical holds. Ideal for chemists, pharmacologists, and regulatory professionals in pharmaceutical R&D, MolWard helps de-risk pipelines before lab work begins. It enables rapid in silico analysis crucial for early-stage drug discovery and development, ensuring compliance and data security.